Penggunaan Highly Active Antiretroviral Theraphy (HAART) Terhadap Health Related Quality of Life (HRQOL) pada Orang Dengan HIV/AIDS

The Role of HlA-antigens in Prurigo Hebra

Human leucoqtle antigens (HI'A) kelas I baik group A maupun B telah diketahui mempunyai hubungan dengan beberapa penyakit kulit, di antaranya psoriasis, dermatitis herpetiformis Duhring, dan lupus erttumatosus. Pada penelitian terdahulu pruigo Hebra (PH) telah diketahui diturunlean secara genetik mengikuti pola penuntnan multifaktor. Selain itu penderttu pH -sangat sensitif terhadap gigitan nya...

Highly Active Antiretroviral Therapy (HAART) and Metabolic Complications

Gynaecomastia associated with highly active antiretroviral therapy (HAART).

There is a global Acquired Immune Deficiency Syndrome (AIDS) epidemic. It is estimated that the total number of people living with Human Immune deficiency Virus (HIV) is 33.2 million in the year 2007. An estimated 2.1 million people died from AIDS in 2007. As highly active antiretroviral therapy (HAART) becomes more widely used, the side effects of this regime are becoming more evident in clini...

Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.

Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities, one of the Achilles' heels of HAART. This article reviews research findings on treatment and QOL out...

Usefulness of highly active antiretroviral therapy on health-related quality of life of adult recipients in Tanzania.

This study assessed health-related quality of life (HRQOL) of highly active antiretroviral therapy (HAART) recipients aged 18 or older and associated factors, 2 years after HAART administration had started in Kagera, Tanzania. Using the 36-Item Short Form Health Survey (SF-36), 329 HAART recipients were interviewed in May 2007. Questions on sociodemographic characteristics, chronic diseases (be...